| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 90.15% | 0.88% | -0.03% | 9/55 | 65.82% | 我武生物 | 95.37% | 行业排名> |
| 2025-06-30 | 90.18% | 0.72% | 0.05% | 8/55 | 67.7% | 我武生物 | 95.1% | 行业排名> |
| 2025-03-31 | 90.14% | 1.59% | 0.64% | 9/55 | 69.02% | 金迪克 | 95.24% | 行业排名> |
| 2024-12-31 | 89.57% | 0.62% | 0.22% | 7/55 | 68.55% | 我武生物 | 95.16% | 行业排名> |
| 2024-09-30 | 89.37% | -0.51% | -0.18% | 8/55 | 69.18% | 我武生物 | 95.26% | 行业排名> |
| 2024-06-30 | 89.53% | 0.08% | 0.91% | 8/55 | 68.3% | 西藏药业 | 95.7% | 行业排名> |
| 2024-03-31 | 88.73% | -0.69% | -0.32% | 10/55 | 69.14% | 康华生物 | 96.08% | 行业排名> |
| 2023-12-31 | 89.02% | 4.18% | -0.91% | 8/55 | 68.02% | 我武生物 | 95.26% | 行业排名> |
| 2023-09-30 | 89.83% | 5.11% | 0.41% | 7/55 | 68.07% | 我武生物 | 95.4% | 行业排名> |
| 2023-06-30 | 89.47% | 4.76% | 0.14% | 9/55 | 63.32% | 华兰疫苗 | 101.02% | 行业排名> |
| 2023-03-31 | 89.35% | 3.42% | 4.57% | 8/55 | 69.48% | 华兰疫苗 | 100.22% | 行业排名> |
| 2022-12-31 | 85.44% | -1.72% | -0.02% | 16/55 | 68.17% | 我武生物 | 95.39% | 行业排名> |
| 2022-09-30 | 85.46% | -1.64% | 0.07% | 18/55 | 71.28% | 我武生物 | 95.63% | 行业排名> |
| 2022-06-30 | 85.41% | -2.89% | -1.14% | 19/55 | 69.18% | 我武生物 | 95.75% | 行业排名> |
| 2022-03-31 | 86.39% | -5.92% | -0.63% | 17/55 | 71.63% | 华兰疫苗 | 98.39% | 行业排名> |
| 2021-12-31 | 86.94% | -6.19% | 0.06% | 19/55 | 72.1% | 百奥泰 | 95.74% | 行业排名> |
| 2021-09-30 | 86.88% | -6.53% | -1.2% | 18/55 | 73.87% | 我武生物 | 95.89% | 行业排名> |
| 2021-06-30 | 87.94% | -5.73% | -4.22% | 14/55 | 73.72% | 百奥泰 | 96.33% | 行业排名> |
| 2021-03-31 | 91.82% | 0.48% | -0.92% | 5/55 | 73.03% | 义翘神州 | 96.83% | 行业排名> |
| 2020-12-31 | 92.67% | -2.03% | -0.3% | 5/55 | 71.61% | 义翘神州 | 96.88% | 行业排名> |
| 2020-09-30 | 92.95% | -1.91% | -0.37% | 4/55 | 73.64% | 义翘神州 | 96.56% | 行业排名> |
| 2020-06-30 | 93.29% | -1.73% | 2.09% | 6/55 | 88.2% | 华兰疫苗 | 707.43% | 行业排名> |
| 2020-03-31 | 91.38% | -3.92% | -3.39% | 5/55 | 70.26% | 我武生物 | 95.6% | 行业排名> |
| 2019-12-31 | 94.59% | -0.54% | -0.18% | 2/55 | 72.44% | 我武生物 | 96.43% | 行业排名> |
| 2019-09-30 | 94.76% | -0.23% | -0.18% | 2/55 | 70.09% | 我武生物 | 96.51% | 行业排名> |
| 2019-06-30 | 94.93% | 0.03% | -0.18% | 2/55 | 69.35% | 我武生物 | 96.46% | 行业排名> |
| 2019-03-31 | 95.1% | 2% | 0% | 2/55 | 69.07% | 我武生物 | 96.44% | 行业排名> |
| 2018-12-31 | 95.1% | 2.94% | 0.13% | 1/55 | 71.54% | 康辰药业 | 95.1% | 行业排名> |
| 2018-09-30 | 94.98% | 2% | 0.09% | 1/55 | 67.51% | 康辰药业 | 94.98% | 行业排名> |
| 2018-06-30 | 94.9% | 6.33% | 2.72% | 1/55 | 67.2% | 康辰药业 | 94.9% | 行业排名> |
| 2017-12-31 | 92.39% | 3.84% | 3.84% | 2/55 | -887.82% | 我武生物 | 93.37% | 行业排名> |
| 2016-12-31 | 88.97% | -1.74% | -0.32% | 8/55 | 68.41% | 我武生物 | 96.35% | 行业排名> |
| 2016-06-30 | 89.25% | 2% | -1.43% | 5/55 | -3007.12% | 我武生物 | 97% | 行业排名> |
| 2015-12-31 | 90.55% | -3.12% | -3.12% | 5/55 | 65.23% | 我武生物 | 96.96% | 行业排名> |

微信公众号
证券之星APP



